Cargando…

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

In the present study we investigated the prognostic value of Circulating Tumour Cells (CTC) and their utility for therapy monitoring in non-small cell lung cancer (NSCLC). A total of 43 patients newly diagnosed with NSCLC were prospectively enrolled. Blood samples were obtained before the 1st, 2nd a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muinelo-Romay, Laura, Vieito, Maria, Abalo, Alicia, Alonso Nocelo, Marta, Barón, Francisco, Anido, Urbano, Brozos, Elena, Vázquez, Francisca, Aguín, Santiago, Abal, Miguel, López López, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980598/ https://www.ncbi.nlm.nih.gov/pubmed/24452143 http://dx.doi.org/10.3390/cancers6010153

Ejemplares similares

Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients
por: León-Mateos, Luis, et al.
Publicado: (2017)

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer
por: Mariscal, Javier, et al.
Publicado: (2016)

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
por: León-Mateos, Luis, et al.
Publicado: (2020)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016)

Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
por: Mondelo‐Macía, Patricia, et al.
Publicado: (2021)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022)

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study
por: Vidal Insua, Yolanda, et al.
Publicado: (2017)

Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
por: Herrero, Carolina, et al.
Publicado: (2020)

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers
por: Brozos-Vázquez, E. M., et al.
Publicado: (2023)

Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer
por: Brozos-Vázquez, Elena, et al.
Publicado: (2023)

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
por: Pereira-Veiga, Thais, et al.
Publicado: (2021)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018)

Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment
por: Piñeiro-Pérez, Raquel, et al.
Publicado: (2022)

Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer
por: Rodríguez-Casanova, Aitor, et al.
Publicado: (2021)

EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
por: Vila, Ana, et al.
Publicado: (2016)

Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report
por: Casas-Arozamena, Carlos, et al.
Publicado: (2022)

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
por: Abreu, Manuel, et al.
Publicado: (2020)

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
por: Costa, Clotilde, et al.
Publicado: (2020)

Association of Salivary Human Papillomavirus Infection and Oral and Oropharyngeal Cancer: A Meta-Analysis
por: Rapado-González, Óscar, et al.
Publicado: (2020)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node
por: Alonso-Nocelo, Marta, et al.
Publicado: (2016)

Integrity and quantity of salivary cell‐free DNA as a potential molecular biomarker in oral cancer: A preliminary study
por: Rapado‐González, Óscar, et al.
Publicado: (2022)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
por: Alonso-Alconada, Lorena, et al.
Publicado: (2014)

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
por: Herrero, Carolina, et al.
Publicado: (2019)

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study
por: Zapatero, Almudena, et al.
Publicado: (2020)

Detection of circulating melanoma cells in choroidal melanocytic lesions
por: Bande, Manuel F., et al.
Publicado: (2015)

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021)

Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
por: Arias-Diaz, Andrea Estrella, et al.
Publicado: (2023)

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
por: Douillard, Jean-Yves, et al.
Publicado: (2014)

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
por: Abreu, Manuel, et al.
Publicado: (2020)

Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients
por: Ribeiro-Samy, Silvina, et al.
Publicado: (2019)

Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c1lu1fo69585dp8rbefritp9bu